Replay available

MiMedx Group, Inc (MDXG) Q3 2025 Earnings Call

MiMedx Group, Inc (NASDAQ: MDXG) Q3 2025 earnings conference call, held 2025-10-29. Replay captured from the company's public earnings webcast.

Wed, October 29, 2025 at 4:30 PMendedReplay
MiMedx Group, Inc (MDXG) Q3 2025 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

Frank Takanaka

Analyst, Lake Street Capital Markets

Anthony Petrone

Analyst, Mizuho Group

Matt Natariani

Head of Investor Relations

Chase Knickerbocker

Analyst, Craig-Hallum Capital Markets

Carl Burns

Analyst, Northland Capital Markets

Joe Capper

Chief Executive Officer

Russ Osborne

Analyst

Doug Rice

Chief Financial Officer

Replay transcript excerpt

Good afternoon, and thank you for standing by. Welcome to the Memetics Third Quarter 2025 Operating and Financial Results Conference Call. At this time, all participants are in listen-only mode. The question-and-answer session will follow the forum presentation. As a reminder, this conference is being recorded. I would now like to turn the conference over to your host, Mr. Matt Natariani, Head of Investor Relations for Memetics. Thank you. You may now begin. Thank you, Operator, and good afternoon, everyone. Welcome to the MiMedx Third Quarter 2025 Operating and Financial Results Conference Call. With me on today's call are Chief Executive Officer Joe Capper and Chief Financial Officer Doug Rice. As part of today's webcast, we are simultaneously displaying slides that you can follow. You can access the slides from the Investor Relations website at MiMedx.com. Joe will kick us off with some opening remarks and a summary of our operating highlights, as well as a discussion of our financial goals, And Doug will provide a review of our financial results for the quarter. And then Joe will conclude before we make ourselves available for your questions. Before we begin, I would like to remind you that our comments today will include forward-looking statements, including statements regarding future sales, operating results, and cash balance growth, future margins and expenses, our product portfolios, and expected market sizes for our product. These expectations are subject to risks and uncertainties, and actual results may differ materially from those anticipated due to many factors, including competition, access to customers, the reimbursement environment, unforeseen circumstances, and delays. Additional factors that could impact outcomes and our results include those descr...

More from Mimedx Group, Inc